Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Atea Pharmaceuticals Inc (AVIR)

Atea Pharmaceuticals Inc (AVIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Atea Pharmaceuticals Inc 225 Franklin Street Suite 2100 BOSTON MA 02110 USA

www.ateapharma.com Employees: 75 P: 857-284-8891

Description:

Atea Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is focused on discovering, developing and commercializing antiviral therapeutics to improve the lives of patients suffering from life-threatening viral infections. Atea Pharmaceuticals Inc. is based in BOSTON.

Key Statistics

Overview:

Market Capitalization, $K 266,903
Enterprise Value, $K 123,083
Shares Outstanding, K 84,463
Annual Sales, $ 0 K
Annual Net Income, $ -135,960 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -31,150 K
EBIT, $ -200,500 K
EBITDA, $ -215,530 K
60-Month Beta 0.17
% of Insider Shareholders 17.80%
% of Institutional Shareholders 86.67%
Float, K 69,429
% Float 82.20%
Short Volume Ratio 0.15

Growth:

1-Year Return 12.02%
3-Year Return -61.18%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.37 on 11/07/24
Next Earnings Date N/A
Earnings Per Share ttm -2.07
EPS Growth vs. Prev Qtr 22.92%
EPS Growth vs. Prev Year 7.50%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

AVIR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -34.90%
Return-on-Assets % -32.38%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.58
Book Value/Share 5.43
Interest Coverage -1.70
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar